DURHAM, N.C.--(BUSINESS WIRE)--Feb. 28, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) today reported financial results for the fourth quarter and year ended December 31, 2005. Total revenue for the fourth quarter of 2005 was $5.2 million compared to $3.7 million for the fourth quarter of 2004. Total revenue for the year ended December 31, 2005 was $23.3 million as compared to $11.1 million for the same period in 2004. Fourth quarter and full year 2005 co-promotion revenues reflect a 41% increase and a 110% increase, respectively, over 2004 amounts. Fiscal 2005 reflects the first complete year of co-promotion revenue of Elestat(R) and Restasis(R), products the Company co-promotes in the United States under agreements with Allergan, Inc.
